Peter G. Czarnecki

1.9k citations

24 papers · 1.1k indexed · 1 hit paper · h-index 14

Nephrology top 2%
- Renal Diseases and Glomerulopathies 5
Genetics top 2%
- Genetic and Kidney Cyst Diseases 13
- Genetic Syndromes and Imprinting 3
Molecular Biology top 10%
- Renal and related cancers 8
- Protist diversity and phylogeny 2
Cell Biology top 10%
Pathology and Forensic Medicine top 10%
Pulmonary and Respiratory Medicine
- Renal cell carcinoma treatment 2
Hematology
- Multiple Myeloma Research and Treatments 2
Infectious Diseases
- COVID-19 Clinical Research Studies 2

Co-authors: Jagesh V. Shah Peter C. Harris Vicente E. Torres Theodore I. Steinman William E. Braun Michael F. Flessner Godela Brosnahan Franz T. Winklhofer
Cited by: Nephrology Genetics Molecular Biology
Journals: Human Molecular Genetics (5 papers)Kidney International Reports (2 papers)New England Journal of Medicine (2 papers)
Partner nations: United States Italy Germany

In The Last Decade

Peter G. Czarnecki

22 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Peter G. Czarnecki

Since Specialization

Citations

This map shows the geographic impact of Peter G. Czarnecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter G. Czarnecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter G. Czarnecki more than expected).

Fields of papers citing papers by Peter G. Czarnecki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter G. Czarnecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter G. Czarnecki. The network helps show where Peter G. Czarnecki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter G. Czarnecki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter G. Czarnecki Line = papers co-authored together Peter G. Czarnecki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Heterozygous Mutations in Three Novel Candidate Genes, IFT122, WDR19, and WDR35, Cause Autosomal Dominant Polycystic Kidney Disease Journal of the American Society of Nephrology ·Alevtina Kodresko,D. Cruz,Guoqiang Wan,阮柳红,A.-M. van Dam,Austin G. Diamond,Giada Bianchi,Jiao Ai-ye,Samer Nasser,Elizabeth A. Phipps,Walter P. Mutter,Emily Robinson,Bilal Onat,Peter G. Czarnecki	2024	0
2	Safety and Diagnostic Yield of Protocolized Percutaneous Kidney Biopsies in Mechanically Ventilated Patients With Acute Kidney Injury Kidney International Reports ·孟琳,Gearoid M. McMahon,David B. Mount,Giada Bianchi,Carol Pierce,Hao Jing-fen,Helmut G. Rennke,Peter G. Czarnecki	2023	0
3	Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy Blood Cancer Journal ·Wolfram Erdmann,Christine‐Ivy Liacos,Volodymyr Chernysh,Foteini Theodorakakou,Despina Fotiou,W Bodger,Mr Matthew William Alfred Dixon,Houry Leblebjian,Eileen Regan,Peter G. Czarnecki,Kimwongil,Niccolò Bolli,Paul G. Richardson,Helmut G. Rennke,Meletios Α. Dimopoulos,Efstathios Kastritis,Giada Bianchi	2023	13
4	Controlled Study of Decision-Making Algorithms for Kidney Replacement Therapy Initiation in Acute Kidney Injury Clinical Journal of the American Society of Nephrology ·Yvelynne P. Kelly,Kavita Mistry,Salman Ahmed,Shimon Shaykevich,Sonali Desai,Stuart R. Lipsitz,David E. Leaf,Ernest I. Mandel,Emily Robinson,Gearoid M. McMahon,Peter G. Czarnecki,David M. Charytan,Sushrut S. Waikar,Mallika L. Mendu	2021	2
5	ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment Blood Cancer Discovery ·Giada Bianchi,Peter G. Czarnecki,Matthew Ho,Aldo M. Roccaro,Antonio Sacco,Yawara Kawano,Annamaria Gullà,Anıl Aktaş Samur,Volodymyr Chernysh,Kenneth Wen,Yu‐Tzu Tai,Wolfram Erdmann,Xinchen Wu,Gulden Camci‐Unal,Matteo Da Vià,Niccolò Bolli,Tomasz Sewastianik,Ruben D. Carrasco,Irene M. Ghobrial,Kenneth C. Anderson	2021	12
6	Targeting Free Light Chain Secretion Via Botulinum Neurotoxin Is a Novel Therapeutic Strategy in AL Amyloidosis By Inducing a Terminal Unfolded Protein Response Blood ·Wolfram Erdmann,Volodymyr Chernysh,Peter G. Czarnecki,Annamaria Gullà,Kenneth C. Anderson,Giada Bianchi	2021	1
7	Filter clotting with continuous renal replacement therapy in COVID-19 Journal of Thrombosis and Thrombolysis ·William J. Hendrick,Rachel Rosovsky,Sophia Zhao,María José Cárcamo Urtasún,Alan Ry,Omer Kamal,Russel J. Roberts,Jianyu Di,Meghan E. Sise,David Steele,Andrew L. Lundquist,Eugene P. Rhee,Kathryn A. Hibbert,C. Corey Hardin,Finnian R. Mc Causland,Peter G. Czarnecki,Walter P. Mutter,Nina Tolkoff-Rubin,Andrew S. Allegretti	2020	18
8	Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease Kidney International Reports ·Matthew Newsome,Kaleab Z. Abebe,K.T. Bae,Diane Comer,Vicente E. Torres,Peter G. Czarnecki,Robert W. Schrier,Theodore I. Steinman,Charity G. Moore,Arlene B. Chapman,Diana Kaya,Cheng Tao,William E. Braun,Franz T. Winklhofer,Godela Brosnahan,Marie C. Hogan,Dana C. Miskulin,Frederic F. Rahbari-Oskoui,Michael F. Flessner,Ronald D. Perrone	2018	7
9	Therapeutic Advances in the Treatment of Polycystic Kidney Disease Nephron Clinical Practice ·Šárka STEJSKALOVÁ,Peter G. Czarnecki,Theodore I. Steinman	2015	15
10	ANKS6 is the critical activator of NEK8 kinase in embryonic situs determination and organ patterning Nature Communications ·Peter G. Czarnecki,George C. Gabriel,Danielle K. Manning,Mikhail Sergeev,Rok Ozebek,Nikolai Klena,Xiaoqin Liu,Yu Chen,You Li,Jovenal T. San Agustin,Maija Garnaas,Richard Francis,Kimimasa Tobita,Wolfram Goessling,Gregory J. Pazour,Cecilia Lo,David R. Beier,Jagesh V. Shah	2015	41
11	Closeout of the HALT-PKD trials Contemporary Clinical Trials ·Charity G. Moore,Susan Spillane,Chibuye Benard Jason,Anisa Hikmah Suryandari,Frederic F. Rahbari-Oskoui,William E. Braun,Arlene B. Chapman,Robert W. Schrier,Vicente E. Torres,Ronald D. Perrone,Theodore I. Steinman,Godela Brosnahan,Peter G. Czarnecki,Peter C. Harris,Dana C. Miskulin,Michael F. Flessner,K.T. Bae,Kaleab Z. Abebe,Marie C. Hogan	2015	1
12	Blood Pressure in Early Autosomal Dominant Polycystic Kidney Diseasebreakdown → New England Journal of Medicine ·Robert W. Schrier,Kaleab Z. Abebe,Ronald D. Perrone,Vicente E. Torres,William E. Braun,Theodore I. Steinman,Franz T. Winklhofer,Godela Brosnahan,Peter G. Czarnecki,Marie C. Hogan,Dana C. Miskulin,Frederic F. Rahbari-Oskoui,Jared J. Grantham,Peter C. Harris,Michael F. Flessner,Kyongtae T. Bae,Charity G. Moore,Arlene B. Chapman	2014	340
13	Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease New England Journal of Medicine ·Vicente E. Torres,Kaleab Z. Abebe,Arlene B. Chapman,Robert W. Schrier,William E. Braun,Theodore I. Steinman,Franz T. Winklhofer,Godela Brosnahan,Peter G. Czarnecki,Marie C. Hogan,Dana C. Miskulin,Frederic F. Rahbari-Oskoui,Jared J. Grantham,Peter C. Harris,Michael F. Flessner,Charity G. Moore,Ronald D. Perrone	2014	189
14	The Meckel syndrome protein meckelin (TMEM67) is a key regulator of cilia function but is not required for tissue planar polarity Human Molecular Genetics ·M Bespalov,Cynthia J. Hommerding,Ying Peng,Jeffrey L. Salisbury,Vladimir G. Gainullin,Peter G. Czarnecki,Caroline R. Sussman,Peter C. Harris	2013	44
15	The ciliary transition zone: from morphology and molecules to medicine Trends in Cell Biology ·Peter G. Czarnecki,Jagesh V. Shah	2012	112
16	B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis Human Molecular Genetics ·Katharina Hopp,Christina M. Heyer,Cynthia J. Hommerding,A. T. Kot,Jamie L. Sundsbak,Cordula Reisch,Б.М. Кумицкий,Mark Consugar,Peter G. Czarnecki,Troy J. Gliem,Vicente E. Torres,Sandro Rossetti,Peter C. Harris	2011	61
17	Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3 Human Molecular Genetics ·Rachaneekorn Tammachote,Cynthia J. Hommerding,Rachel M. Sinders,Caroline A. Miller,Peter G. Czarnecki,M Bespalov,Jeffrey L. Salisbury,Christopher J. Ward,Vicente E. Torres,Vincent H. Gattone,Peter C. Harris	2009	94
18	Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits Kidney International ·Peter G. Czarnecki,Donna J. Lager,Nelson Leung,Angela Dispenzieri,Fernando G. Cosio,Fernando C. Fervenza	2008	47
19	Genetic and physical interaction between the NPHP5 and NPHP6 gene products Human Molecular Genetics ·Tobias Schäfer,Michael Pütz,Soeren S. Lienkamp,Athina Ganner,Astrid Bergbreiter,Haribaskar Ramachandran,Toni De la Calle Villalonga,Martin Gerner,Zihao Zhu,Peter G. Czarnecki,John A. Sayer,Edgar A. Otto,Friedhelm Hildebrandt,Albrecht Kramer-Zucker,Gerd Walz	2008	62
20	Upregulation of the Cochaperone Mdg1 in Endothelial Cells Is Induced by Stress and during in Vitro Angiogenesis Experimental Cell Research ·Felicitas Pröls,Matthias P. Mayer,Oliver Renner,Peter G. Czarnecki,Junaura Rocha Barretto,Claudia S. Gässler,Jörg Wilting,Haymo Kurz,Bodo Christ	2001	29

About Peter G. Czarnecki

Peter G. Czarnecki is a scholar working on Nephrology, Genetics, Molecular Biology, Critical Care and Intensive Care Medicine and Hematology, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Genetic and Kidney Cyst Diseases (13 papers), Renal and related cancers (8 papers), Renal Diseases and Glomerulopathies (5 papers), Genetic Syndromes and Imprinting (3 papers), Renal cell carcinoma treatment (2 papers), Multiple Myeloma Research and Treatments (2 papers), Protist diversity and phylogeny (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Nephrology (235 citations), Genetics (801 citations), Molecular Biology (712 citations), Cell Biology (136 citations) and Pathology and Forensic Medicine (145 citations). Peter G. Czarnecki has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Jagesh V. Shah, Peter C. Harris, Vicente E. Torres, Theodore I. Steinman, William E. Braun, Michael F. Flessner, Godela Brosnahan, Franz T. Winklhofer, Robert W. Schrier and Frederic F. Rahbari-Oskoui. Their work appears in journals such as Human Molecular Genetics, Kidney International Reports, New England Journal of Medicine, Blood and Clinical Journal of the American Society of Nephrology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact